This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Cas Lamvac (Guangzhou) Biomedical Technology Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yinfang Feng: Innovator in Brain Tumor Treatment
Introduction
Yinfang Feng is a notable inventor based in Guangdong, China. He has made significant contributions to the field of biomedical technology, particularly in the development of drugs aimed at treating brain tumors. His innovative approach focuses on enhancing the body's immunological functions to combat this serious health issue.
Latest Patents
Yinfang Feng holds a patent for a drug designed for preventing and/or treating brain tumors. The patent details a drug that comprises various components aimed at regulating immunological functions and inflammation-related factors. This drug has shown significant preventive and therapeutic effects on brain tumors by breaking through the blood-brain barrier, thereby extending the lifespan of patients.
Career Highlights
Feng is currently associated with Cas Lamvac (Guangzhou) Biomedical Technology Co., Ltd., where he continues to work on groundbreaking research and development in the biomedical field. His dedication to improving treatment options for brain tumors has positioned him as a key figure in this area of study.
Collaborations
Yinfang Feng collaborates with talented individuals such as Wenting Ding and Zhipeng Cheng. Their combined expertise contributes to the advancement of innovative solutions in the biomedical sector.
Conclusion
Yinfang Feng's work in developing a drug for brain tumor treatment exemplifies the impact of innovation in healthcare. His contributions are paving the way for improved therapeutic options and better patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile